Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.

作者: Kate M Chitty , Elizabeth Evans , Jennifer J Torr , Teresa Iacono , Henry Brodaty

DOI: 10.1177/0004867415587951

关键词:

摘要: Objective:Information on the rates and predictors of polypharmacy central nervous system medication in older people with intellectual disability is limited, despite increased life expectancy this group. This study examined use an sample disability.Methods:Data regarding demographics, psychiatric diagnoses current medications were collected as part a larger survey completed by carers over age 40 years. Recruitment occurred predominantly via services across different urban rural locations New South Wales Victoria. Medications coded according to Monthly Index Medical Specialties categories, including sedatives/hypnotics, anti-anxiety agents, antipsychotics, antidepressants, stimulants, movement disorder anticonvulsants. The Developmental Behaviour Checklist for Adults was...

参考文章(41)
Perminder S Sachdev, Psychoactive drug use in an institution for intellectually handicapped persons. The Medical Journal of Australia. ,vol. 155, pp. 75- 79 ,(1991) , 10.5694/J.1326-5377.1991.TB142129.X
Robert Pary, Psychoactive drugs used with adults and elderly adults who have mental retardation American Journal on Mental Retardation. ,vol. 98, pp. 121- 127 ,(1993)
Bruininks Rh, Hill Bk, Balow Ea, A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people. Psychopharmacology Bulletin. ,vol. 21, pp. 279- 284 ,(1985)
Tan Doan, Robert Ware, Lyn McPherson, Kate van Dooren, Christopher Bain, Suzanne Carrington, Stewart Einfeld, Bruce Tonge, Nicholas Lennox, Psychotropic medication use in adolescents with intellectual disability living in the community Pharmacoepidemiology and Drug Safety. ,vol. 23, pp. 69- 76 ,(2014) , 10.1002/PDS.3484
C. Bowley, M. Kerr, Epilepsy and intellectual disability Journal of Intellectual Disability Research. ,vol. 44, pp. 529- 543 ,(2000) , 10.1046/J.1365-2788.2000.00270.X
K. McClintock, S. Hall, C. Oliver, Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study. Journal of Intellectual Disability Research. ,vol. 47, pp. 405- 416 ,(2003) , 10.1046/J.1365-2788.2003.00517.X
Gail A. Edelsohn, James M. Schuster, Kim Castelnovo, Lauren Terhorst, Meghna Parthasarathy, Psychotropic Prescribing for Persons With Intellectual Disabilities and Other Psychiatric Disorders Psychiatric Services. ,vol. 65, pp. 201- 207 ,(2014) , 10.1176/APPI.PS.201300029
C. Mohr, B. J. Tonge, S. L. Einfeld, The development of a new measure for the assessment of psychopathology in adults with intellectual disability Journal of Intellectual Disability Research. ,vol. 49, pp. 469- 480 ,(2005) , 10.1111/J.1365-2788.2005.00701.X
Sara Mahan, Jodie Holloway, Jay W. Bamburg, Julie A. Hess, Jill C. Fodstad, Johnny L. Matson, An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID? Research in Developmental Disabilities. ,vol. 31, pp. 1561- 1569 ,(2010) , 10.1016/J.RIDD.2010.05.006